SAN JOSE, Calif. and SWANSEA, Wales, March 12, 2013 /PRNewswire/ -- Cellnovo, developer of the first mobile diabetes management system, and Flextronics (NASDAQ: FLEX), today announced that the two companies have entered into an agreement whereby Flextronics will manufacture and provide design support for the system components of Cellnovo's mobile diabetes management system which includes an insulin pump, cartridge and touch-screen handset.
"In an effort to maximize economies of scale, we made a strategic decision to outsource the manufacturing of our devices and consumables to Flextronics," said Eric Beard , executive chairman at Cellnovo. He added, "We are pleased to partner with Flextronics, a world-class manufacturing organization. Their qualified design and medical manufacturing expertise will enable us to become more competitive by bringing our highly innovative system to the market faster and at lower cost."
"We are thrilled to have been selected by Cellnovo and very happy to partner with them on this ground breaking technology designed to help people with diabetes," said Mark Kemp , president of Flextronics Medical. "Flextronics is committed to providing our customers with advanced innovative solutions and offerings that increase their competitiveness and time to market," he added.
Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to aerospace and defense, automotive, computing, consumer, industrial, infrastructure, medical, energy and mobile OEMs. Flextronics helps customers design, build, ship and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and are vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit www.flextronics.com or follow us on Twitter @flextronics.
A UK-based medical device company, Cellnovo develops an innovative mobile diabetes management system. Comprised of a mobile connected micropump, mobile touchscreen handset/controller, blood glucose meter and applications, the Cellnovo system provides intuitive operation, wireless Internet connectivity and real-time tracking, all industry firsts. For further information, please visit www.cellnovo.com.Renee Brotherton
Kevin KesselCorporate Communications
Investor Relations1 (408) 576-7189
1 (408) email@example.com
Copyright©2012 PR Newswire.
All rights reserved